Results 131 to 140 of about 1,439 (152)

Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials

Expert Opinion on Investigational Drugs, 2020
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is among the most frequent causative agents of acute bacterial skin and skin-structure infections (ABSSSI) and has been associated with increased risks of invasive disease and of treatment ...
Matteo Bassetti, Laura Magnasco, Daniele Roberto Giacobbe   +2 more
exaly   +2 more sources

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.

Journal of Managed Care & Specialty Pharmacy, 2016
BACKGROUND: It is estimated that acute bacterial skin and skin structure infections (ABSSSI) account for nearly 10% of hospital admissions and 3.4-3.8 million emergency department visits per year in the United States.
David P Nicolau, Weihong Fan
exaly   +3 more sources

Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis

Current Medical Research and Opinion, 2015
Objective: The objective was to conduct a systematic review and network meta-analysis (NMA) of existing treatments for ABSSSI focusing on the novel lipoglycopeptide oritavancin. Methods: EMBASE, MEDLINE, MEDLINE in Process, CENTRAL (Cochrane), and
G R Corey
exaly   +2 more sources

Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Open Forum Infectious Diseases, 2017
Background In an effort to lower costs and improve quality of care, there is potential to change the treatment landscape for low-risk (i.e., less severe) ABSSSI patients who historically required inpatient management, a costly option ...
Nicole Bonine, Rajesh Mehta, Iver Juster, Katelyn R Keyloun, Alison Edwards   +4 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI

International Journal of Antimicrobial Agents, 2023
Simone Mornese Pinna, Giusy Tiseo, Evangelos J Giamarellos-Bourboulis   +2 more
exaly  

Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Practice Guidelines for Management and Care Transitions in the Emergency Department and Hospital

Journal of Emergency Medicine, 2015
David A Talan
exaly